
Opinion|Videos|March 18, 2024
Closing Thoughts on the Current Ovarian Cancer Treatment Landscape
Key Takeaways
Ronald D. Alvarez, MD, MBA, provides closing commentary on the current ovarian cancer treatment landscape and the promising outlook over the next 20 years.
Advertisement
Episodes in this series

Newsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on AJMC
1
Trump Announces Deals With Lilly, Novo to Cut Weight Loss Drug Prices
2
Most Favored Nation Drug Pricing Moves Forward, but Experts Warn Details Are Still Missing
3
FDA Approves Lumateperone as Add-On Therapy for Major Depressive Disorder
4
Preventing Tomorrow’s High-Cost Claims: The Rising-Risk Patient Opportunity in Medicaid
5

















































